Stocks Crossing 50-Day SMA 10/22: (HRB) (MDT) (VFC) Above; (GE) (NLSN) (DRYS) Below
- Wall St. falls as data adds to growth worries; biotechs down
- UPDATE: Tesla (TSLA) Tops Q1 EPS by 3c; Plans Q2 Production of ~20,000 Vehicles
- Fitbit (FIT) Tops Q1 EPS by 7c; Issues Mixed Outlook
- TripAdvisor (TRIP) Misses Q1 EPS by 14c
- After-Hours Stock Movers 05/04: (EPE) (ZNGA) (WTW) Higher; (FRSH) (RRTS) (FIT) Lower (more...)
Crossing and above:
- H&R Block, Inc. (NYSE: HRB) - up 3.3 percent. BTIG initiated coverage on the stock at Buy and $23 target.
- Medtronic (Nasdaq: MDT) - up 0.5 percent. Higher after reporting that Resolute did not increase rates of stent thrombosis one year after interrupting dual antiplatelet therapy after 30 days following usage of the stent.
- V.F. Corp. (NYSE: VFC) - down 5.0 percent. VF reported Q3 EPS of $3.52 and revs of $3.1 billion, versus consensus estimates EPS estimate of $3.49 and revs of $3.17 billion.
VF sees FY2012 EPS of $9.60, versus prior guidance of $9.50 and the consensus of $9.54.
- General Electric (NYSE: GE) - down percent. Still pressured from last Friday's quarterly results. Nomura issued positive comments on the stock this morning.
- Nielsen Holdings (NYSE: NLSN) - down 7.1 percent. Topped Q3 EPS views by 3 cents per share, while revs of $1.42 billion were a little light.
- DryShips, Inc. (Nasdaq: DRYS) - down 1.9 percent. The shipping segment -- both dry bulk and crude shippers -- are seeing a little pressure following Overseas Shipholding (NYSE: OSG) saying it might explore strategic alternatives.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Valeant Pharma (VRX) Adds to Yesterday's Gains
- Eleven Biotherapeutics (EBIO) Surges for Second Day Following New Data
- Children's Place (PLCE) Rated New Sell at Off Wall Street
Create E-mail Alert Related CategoriesSpecial Reports, Technicals, Trader Talk
Related EntitiesNomura, Crude Oil, Stocks crossing the 50-day simple moving average
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!